Comment on: "CYP3A4*22 Genotype‑Guided Dosing of Kinase Inhibitors in Cancer Patients"

Clin Pharmacokinet. 2024 May 11. doi: 10.1007/s40262-024-01380-5. Online ahead of print.
No abstract available

Publication types

  • Letter
  • Comment